询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交
中文版 English
请输入产品名称、CAS式、分子式
8-Bromo-1-naphthoic acid | CAS:1729-99-3
8-Bromo-1-naphthoic acid
  • 名称:8-溴-1-萘甲酸 | 8-Bromo-1-naphthoic acid
  • CAS号:1729-99-3
  • 别名:
  • 分子式:C11H7BrO2
  • 分子量:251.08
  • EINESC号:217-045-9

产品描述

物理化学性质

熔点 169-171 ºC

安全数据

安全说明书 S24/25

SDS

来源 SDS样本
Sigma-Aldrich 浏览或下载
Syn-Quest 浏览或下载
Oakwood 浏览或下载
产品合成路线
更多

名称 CAS号
更多
文章
同行评议文献
The evaluation of ozone and betahistine in the treatment of tinnitus.Onur Sönmez et al.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 270(7), 1999-2006 (2012-10-27) Betahistine or Cinnarizine for treatment of Meniere's disease.Jasminka Djelilovic-Vranic et al.Medical archives (Sarajevo, Bosnia and Herzegovina), 66(6), 396-398 (2013-02-16) [Vertigo: patient management tactics].I S Vasyl'chuk et al.Likars'ka sprava, (7)(7), 84-87 (2013-01-29) Betahistine dihydrochloride or betahistine mesilate: two sides of the same coin or two different coins.Hazra A, et al. International Journal of Basic & Clinical Pharmacology, 6(8), 1833-1840 (2017) Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies.Rania M Hathout et al.Colloids and surfaces. B, Biointerfaces, 110, 254-260 (2013-06-05) Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.R Gürkov et al.The Journal of laryngology and otology, 126(4), 356-362 (2012-03-01) [Clinical effectiveness and safety of sanchi tong shu capsule in the treatment of aural vertigo: a multi-center randomized controlled clinical trial].Juan Meng et al.Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 26(7), 295-299 (2012-06-29) Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.Christine Adrion et al.BMC medical research methodology, 12, 137-137 (2012-09-12) [Efficacy of vestibo in the treatment of vertebrobasilar insufficiency].E I Chukanova et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(4), 53-56 (2012-07-20) Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.Arne-Wulf Scholtz et al.Clinical drug investigation, 32(6), 387-399 (2012-04-18) Histamine and antipsychotic drug-induced weight gain.Gavin P Reynolds Journal of psychopharmacology (Oxford, England), 26(12), 1608-1609 (2012-11-30) Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.Michael Poyurovsky et al.Psychopharmacology, 226(3), 615-622 (2012-12-15) Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.D Monzani et al.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 32(6), 393-403 (2013-01-26) Menière-like syndrome in Camurati-Engelmann disease.Lea Pollak The Israel Medical Association journal : IMAJ, 15(7), 390-391 (2013-08-16) Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study.R Gürkov et al.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 270(4), 1231-1235 (2012-07-05) Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.G Desmadryl et al.British journal of pharmacology, 167(4), 905-916 (2012-05-26) Looks vestibular: irrational prescribing of antivertiginous drugs for older dizzy patients in general practice.Otto R Maarsingh et al.The British journal of general practice : the journal of the Royal College of General Practitioners, 62(603), 518-520 (2012-12-26) [The effect of betahistine on histological changes in rabbit brain in model of whole body wide-frequency vibration].Iu Iu Shimkus et al.Eksperimental'naia i klinicheskaia farmakologiia, 76(6), 14-17 (2013-09-06) Meniere's disease: an evidence based approach to assessment and management.I Syed et al.International journal of clinical practice, 66(2), 166-170 (2012-01-20) Effectiveness of the combined hearing and masking devices on the severity and perception of tinnitus: a randomized, controlled, double-blind study.Isilay Oz et al.ORL; journal for oto-rhino-laryngology and its related specialties, 75(4), 211-220 (2013-08-01) Benign paroxysmal positional vertigo (BPPV): influence of pharmacotherapy and rehabilitation therapy on patients' recovery rate and life quality.Sinisa Maslovara et al.NeuroRehabilitation, 31(4), 435-441 (2012-12-13) Involvement of histamine receptors in SAPK/JNK phosphorylation.Radhika D Dandekar et al.International immunopharmacology, 13(2), 190-196 (2012-04-11) Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.Chao Deng et al.Journal of psychopharmacology (Oxford, England), 26(9), 1271-1279 (2012-06-15) [Treatment of vestibular vertigo and Ménière syndrome in outpatient clinics].E V Kostenko et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(12), 36-40 (2013-02-08) Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo.Fritz Ihler et al.PloS one, 7(6), e39086-e39086 (2012-06-30) Vestibular rehabilitation with virtual reality in Ménière's disease.Adriana Pontin Garcia et al.Brazilian journal of otorhinolaryngology, 79(3), 366-374 (2013-06-08)
备注

Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

名称 CAS号

相关产品

相关资讯

热门标签
询 单
请 填 写 相 关 信 息
产品信息
产品名称
别名
CAS号
结构式 上传
联系方式
公司
联系人
电话
邮箱
内容
提交